These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12883335)

  • 1. Amlodipine improves vascular function in patients with moderate to severe hypertension.
    Ohtsuka S; Yamazaki A; Oyake Y; Yamaguchi I
    J Cardiovasc Pharmacol; 2003 Aug; 42(2):296-303. PubMed ID: 12883335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of endothelial function by amlodipine and vitamin C in essential hypertension.
    On YK; Kim CH; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Korean J Intern Med; 2002 Jun; 17(2):131-7. PubMed ID: 12164090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension.
    On YK; Kim CH; Oh BH; Lee MM; Park YB
    Hypertens Res; 2002 May; 25(3):365-71. PubMed ID: 12135314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
    Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.
    Schiffrin EL; Pu Q; Park JB
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):105-10. PubMed ID: 11863244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients.
    Taddei S; Virdis A; Ghiadoni L; Uleri S; Magagna A; Salvetti A
    Hypertension; 1997 Dec; 30(6):1606-12. PubMed ID: 9403590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
    Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
    Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
    J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of amlodipine on cerebral circulatory values in patients with essential hypertension.
    Alizade IG; Karayeva NT
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):14-6. PubMed ID: 12122965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amlodipine on norepinephrine kinetics and baroreflex function in patients with congestive heart failure.
    Goldsmith SR
    Am Heart J; 1997 Jul; 134(1):13-9. PubMed ID: 9266778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.
    White WB; Duprez D; St Hillaire R; Krause S; Roniker B; Kuse-Hamilton J; Weber MA
    Hypertension; 2003 May; 41(5):1021-6. PubMed ID: 12682082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress impairs endothelial function in nondipper hypertensive patients.
    Maio R; Perticone M; Sciacqua A; Tassone EJ; Naccarato P; Bagnato C; Iannopollo G; Sesti G; Perticone F
    Cardiovasc Ther; 2012 Apr; 30(2):85-92. PubMed ID: 20553284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of AT1 inhibition and Ca2+-channel blockade in hypertensive patients during isometric stress.
    Arosio E; De Marchi S; Prior M; Rigoni A; Lechi A
    J Hum Hypertens; 2006 Mar; 20(3):201-5. PubMed ID: 16319906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
    Takei K; Araki N; Ohkubo T; Tamura N; Yamamoto T; Furuya D; Yanagisawa CT; Shimazu K
    Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension.
    Iwatsubo H; Nagano M; Sakai T; Kumamoto K; Morita R; Higaki J; Ogihara T; Hata T
    Hypertension; 1997 Jan; 29(1 Pt 2):286-90. PubMed ID: 9039116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.